PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Recruiting now · Not applicable
Conditions studied: Lung Carcinoma, Esophageal Carcinoma
In brief
This clinical trial examines positron emission tomography (PET)/computed tomography (CT) in evaluating cardiac radiation damage in patients with lung or esophageal cancer. As part of the treatment for lung or esophageal cancer, patients will undergo radiation therapy. Sometimes, during this treatment, the heart is also subjected to some radiation which could affect its function, either increasing or decreasing the function. It is not known the consequences of this change nor is it known if doctors can detect the changes associated with the radiation. Sarcoidosis FDG positron emission tomography (PET)-computed tomography (CT) scans are a common way to image cardiac inflammation and myocardial viability. This study may help doctors image the heart before, during and after radiotherapy to monitor any changes.
Key facts
- Study ID
- NCT05775939
- Run by
- Thomas Jefferson University
- People needed
- 20
- Starts
- 2023-01-20
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-02-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, aged >= 18
- Life expectancy >= 3 months as assessed by Radiation Oncologist
- Mean heart dose estimated by Radiation Oncologist to be >= 5 Gy (physics dose or biologically equivalent dose)
- Pathologically proven (either histologic or cytologic) proven lung cancer or esophageal cancer
- Planned radiation treatment course for management of lung or esophageal cancer * Both standard and hypofractionation schedules are permitted
You may not qualify if…
- Contraindication for FDG PET-CT scans as assessed by the radiation oncologist or nuclear medicine radiologist
- Palliative radiation doses defined as 20 Gy in 5 fractions
Where it is running
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.